Why the Little Green Pharma (ASX:LGP) share price is edging higher

The Little Green Pharma (ASX: LGP) share price is on the move after news the company’s medicinal cannabis products will be sold in Denmark.
The post Why the Little Green Pharma (ASX:LGP) share price is edging higher appeared first on The Motley Fool Australia. –

cannabis leaves on a rising line graph representing growth of ASX cannabis share price

Little Green Pharma Ltd (ASX: LGP) shares are on the rise this morning following the company’s announcement of a new European distribution deal. The Australian medicinal cannabis manufacturer has signed an agreement that will see its products sold in Denmark. At the time of writing, the Little Green Pharma share price is trading 1.31% higher at 77.5 cents.

Let’s look closer at the company’s latest news.

Distribution in Denmark

Little Green Pharma has signed a 5-year, non-exclusive distribution agreement with Balancial Danmark ApS.

The agreement will see Balancial distributing Little Green Pharma-branded cannabis oil and flower medicines in the Scandinavian nation.

According to the company’s release, the deal is another step in its plan to grow its market share in key European medicinal cannabis markets.

It has already nabbed entry points into Germany, France, and the United Kingdom.

The agreement comes with certain terms and conditions. One being that Balancial cannot market or manufacture any other cannabis oil or flower products in Denmark until it has ordered 20,000 units from the Australian company.

 Another is that the Danish company must order at least 2,000 units per shipment, on a continuous basis.

Denmark is currently more than 3 years into a 4-year trial period for the use of medicinal cannabis products. Within the trial, medicinal cannabis prescriptions are 50% reimbursed (up to US$1,500 per year) by the state, and fully reimbursed for terminally ill patients.

Little Green Pharma states, since the trial’s introduction, medicinal cannabis patient count and prescription volumes have been growing quickly. As of February 2020, the market was expected to be worth 500 million euros and represent 2% of the population by maturity.

Commentary from management

Little Green Pharma’s managing director Fleta Solomon commented on the agreement:

LGP is pleased to announce another agreement for the distribution of LGP products into a prospective EU medicinal cannabis marketplace, and looks forward to collaborating with Balancial to help service our future Danish customers.

Little Green Pharma share price snapshot

The Little Green Pharma share price has been performing well on the ASX lately.

Currently, the company’s share price is up by around 38% year to date. It’s also up by around 158% over the last 12 months.

The company has a market capitalisation of around $101 million, with approximately 187 million shares outstanding.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Little Green Pharma (ASX:LGP) share price is edging higher appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!